Matches in Nanopublications for { ?s ?p "[Somatic mutation in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR) gene is associated with the sensitivity of non-smal cell lung cancer (NSCLC) to TK inhibitor Gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP97149.RAwv84gMSaZfYaCNpUqzPvhFdyBLV9BXMFAccVvMTZLw0130_assertion description "[Somatic mutation in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR) gene is associated with the sensitivity of non-smal cell lung cancer (NSCLC) to TK inhibitor Gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP97149.RAwv84gMSaZfYaCNpUqzPvhFdyBLV9BXMFAccVvMTZLw0130_provenance.
- assertion description "[Somatic mutation in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR) gene is associated with the sensitivity of non-smal cell lung cancer (NSCLC) to TK inhibitor Gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP225889.RAYjV6K21vBPSlJLClAm6xSI9hJEzBDstLkRXcy9HHNmQ130_assertion description "[Somatic mutation in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR) gene is associated with the sensitivity of non-smal cell lung cancer (NSCLC) to TK inhibitor Gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP225889.RAYjV6K21vBPSlJLClAm6xSI9hJEzBDstLkRXcy9HHNmQ130_provenance.